Table 2.
Venous and arterial thrombotic events.
| Patients | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Age (yrs.) | 58 | 84 | 82 | 86 | 92 | 83 |
| Sex | Male | Male | Male | Male | Female | Male |
| CVRF | No | No | HBP; DM | HBP | HBP | HBP; DLP |
| Thrombotic history | No | Yes | Yes | No | No | Yes |
| Days from disease onset to thrombotic event | 14 | 5 | 28 | 1 | 10 | 1 |
| Platelets (109/L) | 241 | 224 | 188 | 244 | 180 | 194 |
| LA | Positive | Negative | Negative | Positive | Positive | Negative |
| APA | Negative | Negative | Negative | Negative | Not done | Negative |
| DD (ng/mL) | 2651 | 169 | 594 | 1935 | 697 | 19,865 |
| Thrombosis location | PE | AMI | AMI | AIS | AMI | PE/AIS |
| Diagnostic test | Thorax CT scan | EKG; blood analysis | EKG; blood analysis | Cerebral CT scan | EKG; blood analysis | Thorax & Cerebral CT scan |
| Bilateral and diffuse PE with involvement of the segmentation arteries. | 2 mm elevation in V1-V2 and AVR derivations; | Distal occlusion of right mean cerebral arterial. | Negative T-waves in V2-V6 derivations; | Defects of repletion in the interlobular branches of the right hemithorax and the lobar branches of the left lobe. | ||
| Troponin 1440 ng/L. | Troponin 1657 ng/L. | Troponin 767.9 ng/L. | Stroke in mid-right cerebral artery. | |||
| Anticoagulant before thrombosis | No | No | No | No | Yes | No/Yes |
| Days | – | – | – | – | 1 | 1 |
| Drug | Enoxaparin | Enoxaparin | ||||
| Dosage | 1 mg/Kg/12 h | 1 mg/Kg/12 h | ||||
| Antiplatelet drug previous | No | Yes | Yes | No | No | No |
| Death during hospitalization | No | No | Yes | No | No | No |
CVRF: cardiovascular risk factors; DM: Diabetes Mellitus; LA: lupus anticoagulant; HBP: High blood pressure; APA: antiphospholipid antibodies; DLP: dyslipidemia; ACL: cardiolipin antibodies; B2GP: beta-2-glycoprotein antibodies; DD: d-dimer; CT: computerized tomography; PE: pulmonary embolism; AMI: acute myocardial infarction; AIS: acute ischemic stroke; DVT: deep vein thrombosis; EKG: electrocardiogram.